tiprankstipranks
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market

TriSalus Life Sciences (TLSI) Financial Statements

Compare
50 Followers

TriSalus Life Sciences Financial Overview

TriSalus Life Sciences's market cap is currently $174.42M. The company's EPS TTM is $-2.499; its P/E ratio is ―; TriSalus Life Sciences is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 18.51M$ 12.40M$ 8.40M$ 5.43M
Gross Profit$ 15.91M$ 10.14M$ 7.21M$ 3.24M
Operating Income$ -54.15M$ -36.44M$ -24.03M$ -25.65M
EBITDA$ -58.30M$ -46.76M$ -23.57M$ -25.32M
Net Income$ -59.04M$ -47.19M$ -28.84M$ -31.83M
Balance Sheet
Cash & Short-Term Investments$ 11.78M$ 9.41M$ 30.30M$ 1.33M
Total Assets$ 25.73M$ 22.00M$ 37.84M$ 252.01M
Total Debt$ 1.59M$ 1.96M$ 544.00K$ 42.18M
Net Debt$ -10.18M$ -7.45M$ -29.76M$ 40.85M
Total Liabilities$ 51.66M$ 198.32M$ 167.44M$ 23.50M
Stockholders' Equity$ -25.94M$ -176.33M$ -129.60M$ 228.52M
Cash Flow
Free Cash Flow$ -51.17M$ -33.10M$ -23.95M$ -1.22M
Operating Cash Flow$ -50.05M$ -32.31M$ -22.70M$ -677.60K
Investing Cash Flow$ -2.12M$ -1.79M$ -2.26M$ -250.00M
Financing Cash Flow$ 54.63M$ 13.46M$ 50.77M$ 252.01M
Currency in USD

TriSalus Life Sciences Earnings and Revenue History

TriSalus Life Sciences Debt to Assets

TriSalus Life Sciences Cash Flow

TriSalus Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis